Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts. Asano Y, Han Q, Li S, Mizuta K, et al. Anticancer Res 2025;45:2257-2263.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Asano Y, Han Q, Li S, Mizuta K, et al. Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts. Anticancer Res 2025;45:2257-2263.
PMID: 40425329